Fig. 3From: Unpacking overuse of androgen deprivation therapy for prostate cancer to inform de-implementation strategiesDiscrete choice experiment partworths utilities for communication, multidisciplinary review, documentation, and support tools according to whether provider respondents would or would not stop low-value ADTBack to article page